Bristol-Myers Squibb Company is a large U.S.-based biopharmaceutical company that develops and sells prescription medicines. Its filings show it lobbies Congress on drug and health matters such as 340B program changes, FDA drug approvals, drug pricing policies (including implementation of the Inflation Reduction Act and most-favored-nation approaches), Medicare/Medicaid access and coverage, pharmaceutical supply chain and importation, and intellectual property and trade issues. It reported $130,000 across three filings and uses the firm Williams & Jensen for lobbying.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
JEANNE HAGGERTY
The latest disclosures for this client.
WILLIAMS AND JENSEN, PLLC
Q2WILLIAMS AND JENSEN, PLLC
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
WILLIAMS AND JENSEN, PLLC
ROBERT BUTORA
WILLIAMS AND JENSEN, PLLC
SUSAN HIRSCHMANN
WILLIAMS AND JENSEN, PLLC
KURT SCHRADER
WILLIAMS AND JENSEN, PLLC
CHRISTOPHER E. WILCOX
WILLIAMS AND JENSEN, PLLC
mr CHRISTOPHER W HATCHER
WILLIAMS AND JENSEN, PLLC
WILLIAMS AND JENSEN, PLLC
Q4WILLIAMS AND JENSEN, PLLC
Q3WILLIAMS AND JENSEN, PLLC
RA